A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4(+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment. [electronic resource]
Producer: 20110728Description: 384-92 p. digitalISSN:- 1365-2893
- Adult
- Antigens, CD -- metabolism
- Antigens, CD19 -- metabolism
- Antiviral Agents -- therapeutic use
- B-Lymphocyte Subsets -- drug effects
- Drug Therapy, Combination
- Female
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Liver Cirrhosis -- drug therapy
- Male
- Middle Aged
- Polyethylene Glycols -- therapeutic use
- Prospective Studies
- Recombinant Proteins
- Ribavirin -- therapeutic use
- T-Lymphocyte Subsets -- drug effects
- T-Lymphocytes, Regulatory -- drug effects
- Tetraspanin 28
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.